Double-blind comparison between 4-allyloxy-3-chlorophenylacetic acid (alclofenac) and phenylbutazone in osteoarthritis.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D010003:Osteoarthritis / Q000188:drug therapy*; D010636:Phenols / Q000627:therapeutic use; D010648:Phenylacetates / Q000009:adverse effects / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010636:Phenols; D010648:Phenylacetates; D010653:Phenylbutazone